Mardil, Inc. announced positive interim data from a pilot study investigating the safety and efficacy of its novel cardiac device BACE (Basal Annuloplasty of the Cardia Externally) in treating mitral valve regurgitation. The condition arises when the hearts mitral valve leaks blood backward into the heart, causing a range of severe and debilitating [...]

Rexahn Pharmaceuticals, Inc. (NYSE Amex RNN) announced preliminary results for its sexual dysfunction drug candidate, Zoraxel™, from a Phase IIa clinical study for the treatment of erectile dysfunction (ED). The double blind, randomized, placebocontrolled, dose ranging study found that human subjects treated with Zoraxel demonstrated improved erectile function as measured by changes over the International [...]